 |
 |

Elejalde SyndromeA Melanolysosomal Neurocutaneous Syndrome
Clinical and Morphological Findings in 7 Patients
Carola Durán-McKinster, MD;
Rodolfo Rodriguez-Jurado, MD;
Cecilia Ridaura, MD;
M. A. de la Luz Orozco-Covarrubias, MD;
Lourdes Tamayo, MD;
Ramon Ruiz-Maldonando, MD
Arch Dermatol. 1999;135:182-186.
Background Silvery hair and severe dysfunction of the central nervous system (neuroectodermal melanolysosomal disease or Elejalde syndrome) characterize this rare autosomal recessive disease. Main clinical features include silver-leaden hair, bronze skin after sun exposure, and neurologic involvement (seizures, severe hypotonia, and mental retardation). Large granules of melanin unevenly distributed in the hair shaft are observed. Abnormal melanocytes and melanosomes and abnormal inclusion bodies in fibroblasts may be present. Differential diagnosis with Chédiak-Higashi syndrome and Griscelli syndrome must be done.
Observations We studied pediatric patients with silvery hair and profound neurologic dysfunction. Immune impairment was absent. Age of onset of neurologic signs ranged from 1 month to 11 years; the signs included severe muscular hypotonia, ocular alterations, and seizures. Mental retardation since the first months of life was noted in 4 cases. Psychomotor development was normal in 3 cases, but suddenly the patients presented with a regressive neurologic process. Four patients died between 6 months and 3 years after the onset of neurologic dysfunction. One patient showed characteristic ultrastructural findings of Elejalde syndrome.
Conclusions Elejalde syndrome is different from Chédiak-Higashi and Griscelli syndrome and is characterized by silvery hair and frequent occurrence of fatal neurologic alterations. Psychomotor impairment may have 2 forms of presentation: congenital or infantile. Although Elejalde syndrome and Griscelli syndrome are similar, the possibility that they are 2 different diseases, although probably allelic related, is suggested.
From the Departments of Dermatology (Drs Duran-McKinster, de la Luz Orozco-Covarrubias, Tamayo, and Ruiz-Maldonando) and Pathology (Drs Rodriguez-Jurado and Ridaura), National Institute of Pediatrics, Mexico City, Mexico.
RELATED ARTICLE
Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 1999;135(2):226-227.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Griscelli Syndrome Type 2: A Rare and Lethal Disorder
Masri et al.
J Child Neurol 2008;23:964-967.
ABSTRACT
Myosin Va Controls Oligodendrocyte Morphogenesis and Myelination
Sloane and Vartanian
J. Neurosci. 2007;27:11366-11375.
ABSTRACT
| FULL TEXT
Cargos and genes: insights into vesicular transport from inherited human disease
Gissen and Maher
J. Med. Genet. 2007;44:545-555.
ABSTRACT
| FULL TEXT
Myosin Va is required for normal photoreceptor synaptic activity
Libby et al.
J. Cell Sci. 2004;117:4509-4515.
ABSTRACT
| FULL TEXT
Elejalde Syndrome Revisited
Lambert et al.
Arch Dermatol 2000;136:120-121.
FULL TEXT
|